Cynosure Group LLC Invests $495,000 in Morgan Stanley $MS

Cynosure Group LLC bought a new position in Morgan Stanley (NYSE:MS) during the 4th quarter, Holdings Channel reports. The firm bought 2,789 shares of the financial services provider’s stock, valued at approximately $495,000.

Several other institutional investors and hedge funds have also modified their holdings of MS. Motiv8 Investments LLC acquired a new position in shares of Morgan Stanley in the 4th quarter worth approximately $25,000. Olistico Wealth LLC acquired a new position in shares of Morgan Stanley in the 4th quarter worth approximately $27,000. Lodestone Wealth Management LLC acquired a new position in shares of Morgan Stanley in the 4th quarter worth approximately $28,000. WFA of San Diego LLC acquired a new position in shares of Morgan Stanley in the 2nd quarter worth approximately $28,000. Finally, Nvest Wealth Strategies Inc. acquired a new position in shares of Morgan Stanley in the 4th quarter worth approximately $31,000. 84.19% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Morgan Stanley

Here are the key news stories impacting Morgan Stanley this week:

• Positive Sentiment: Morgan Stanley said the bull market remains intact and could broaden further as investors rotate into cyclical sectors. The ‘Bull Market Is Intact,’ Says Morgan Stanley
• Positive Sentiment: The firm also highlighted stocks that can keep the rally going, reinforcing Morgan Stanley’s influence on market positioning and investor sentiment. These stocks have been beating the S&P 500 and could keep the bull market going, says Morgan Stanley
• Neutral Sentiment: Morgan Stanley was also in the news for stock-specific research calls, including upgrades and target hikes on names tied to AI infrastructure, data storage, and industrials, which reflects active and influential equity research coverage. Morgan Stanley (MS) Pounds the Table on These Data Storage Names

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Royal Bank Of Canada reissued a “sector perform” rating and issued a $207.00 target price on shares of Morgan Stanley in a report on Thursday, April 16th. Bank of America boosted their price objective on shares of Morgan Stanley from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Thursday, April 16th. Daiwa Securities Group boosted their price objective on shares of Morgan Stanley from $175.00 to $198.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 5th. Dbs Bank boosted their price objective on shares of Morgan Stanley from $185.00 to $220.00 in a research report on Thursday, May 7th. Finally, Erste Group Bank upgraded shares of Morgan Stanley from a “hold” rating to a “buy” rating in a research report on Monday, April 27th. Twelve research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $206.35.

Insider Buying and Selling at Morgan Stanley

In other Morgan Stanley news, insider Andrew M. Saperstein sold 51,668 shares of the company’s stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $188.59, for a total transaction of $9,744,068.12. Following the completion of the sale, the insider owned 282,142 shares in the company, valued at approximately $53,209,159.78. The trade was a 15.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Eric F. Grossman sold 11,118 shares of the company’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $190.75, for a total transaction of $2,120,758.50. Following the sale, the insider owned 169,403 shares of the company’s stock, valued at $32,313,622.25. The trade was a 6.16% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 77,476 shares of company stock worth $14,644,762. Insiders own 0.17% of the company’s stock.

Morgan Stanley Stock Performance

MS stock opened at $220.65 on Wednesday. The company has a 50 day moving average price of $195.85 and a 200 day moving average price of $181.71. The stock has a market capitalization of $348.03 billion, a PE ratio of 19.99, a price-to-earnings-growth ratio of 1.63 and a beta of 1.23. Morgan Stanley has a fifty-two week low of $129.66 and a fifty-two week high of $222.30. The company has a debt-to-equity ratio of 3.52, a current ratio of 0.77 and a quick ratio of 0.77.

Morgan Stanley (NYSE:MS) last issued its earnings results on Wednesday, April 15th. The financial services provider reported $3.43 EPS for the quarter, beating the consensus estimate of $3.02 by $0.41. The company had revenue of $20.58 billion during the quarter, compared to analysts’ expectations of $19.23 billion. Morgan Stanley had a net margin of 14.65% and a return on equity of 17.70%. The business’s revenue for the quarter was up 16.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.60 EPS. Analysts forecast that Morgan Stanley will post 11.87 EPS for the current year.

Morgan Stanley Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Thursday, April 30th were given a dividend of $1.00 per share. The ex-dividend date was Thursday, April 30th. This represents a $4.00 annualized dividend and a dividend yield of 1.8%. Morgan Stanley’s payout ratio is presently 36.23%.

Morgan Stanley Company Profile

Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.

The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.